chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up with a headache and I just started having headaches. I had headaches everyday. At first it was just a headache and I was just taking over the counter medication for it. Then it just went into a migraine and once I got it I couldn't break it. They gave me a migraine mix the first day I went to the hospital and it didn't help. They ended up giving me imtrex in the stomach. That ended up breaking the migraine. Then at 05:00AM in the morning it came back. I went back in and they gave me something to my head. Something for when I have severe migraines, a shot in the head. That didn't help my migraine and then they gave me the tirastol. Then they gave me some to take home so I could have it at home when my head was hurting. It would break it for a little while but it would still come right back. I had a migraine for 22 days straight.
Information has been received from a physician concerning a 17 year old female with no known drug allergies, cholelithiasis, gastroesophageal reflux disease and Raynaud's with a family history of systemic lupus erythematosus who on 26-SEP-2007, received 0.5 ccs subcutaneous of varicella virus vaccine live (Oka/Merck) (lot# "3069U"). Concomitant therapy included Menactra vaccine (lot# C834U). On 27-SEP-2007, the physician received a phone call reporting that her arm got red, warm and was tender. Treatment included ice and Benadryl. On 29-SEP-2007, she was seen by the physician who reported that the majority of th symptoms were at the site of the varicella vaccine live (Oka/Merck) (MSD) and not at the Menactra site, and the symptoms had mostly resolved. No product quality complaint was reported. No further information was available. Additional information has been requested.
I assume the vaccine was administered. Pt developed mild generalized vaccinia. Weeping lesion in left axilla with lymphongitis multiple lesions of thorax.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 59-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FA7484), at the age of 59, in left arm, on Aug 4, 2021, at 12:30, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had fatigue (after 1st dose, felt tired the following day), onset Aug 5, 2021, with outcome of unknown. Therapeutic measures were taken as a result of fatigue. Additional information: Patient felt tired the following day after 1st dose. Patient took 2 Motrins. Prior vaccination: none. No follow-up attempts possible. No further information expected.
30 minuets after receiving vaccine, I was driving home and my lips started tingling, my skin on my face felt tight.  This eventually subsided and went away in about an hour.
Ringing in both ears; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER 8732) via an unspecified route of administration in the left arm on 24Mar2021 at 10:45 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. Medical history included Chronic Obstructive Pulmonary Disease (COPD). The patient was allergic to collins, sulpha base and blue berries. Concomitant medications included NAZARETH (unspecified medication) and albuterol inhaler (MANUFACTURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced ringing in both ears on 24Mar2021 at 20:30. The patient did not receive treatment for the reported events. The events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The clinical outcome of ringing in both ears was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Pericarditis is the inflamtion of the peridium. I've had mild inflamtion in the past. It maybe just a coincidence but unlikely that an attack is taking place two days after the second dose and this attack is directly related to the covid vaccine.
Pt -recv vax on 5/29/98; on 6/7/98 pt exp rash over entire body, sore, stiff neck, sore throat, swollen lymph nodes, joint pain, itching
Per wife, Approximately 1 week post vaccination patient experienced paralysis, inability to control bladder, forgetfulness, and inability to perform daily activities such as operating television remote.
The morning extreme chills with a red, hot, hard 3"x4" localized reaction. Ran fevers for three days with the highest 103.5. The localized reaction continued to grow to 4"x4" with swollen lymph needs in that axilla.
Sore arm for 2 days,  nausea for 3 days, lack of appetite for 2 days, fatigue and trouble sleeping
This spontaneous report as received from a registered nurse refers to a 13 year old patient who on 28-JUN-2013, was inadvertently vaccinated with a dose of PROQUAD (lot # H020134, Exp. Date: 07-MAY-2014) subcutaneous (dose not reported). The patient had an unknown vaccination history and it was unspecified if this was the first dose of varicella vaccine that the patient ever received. No adverse effects were reported. Additional information has been requested.
This spontaneous report was received from a pharmacy intern, referring to a female patient of an unknown age. The patient's pertinent medical history, drug reaction or allergies were not reported. On 30-JAN-2016, the patient was vaccinated with ZOSTAVAX 19400 PFU lot # L032402, expiration date 26-NOV-2016 (dose, route of administration and anatomical location were not reported). Concomitant medications were unknown. On 16-FEB-2016, the patient submitted a prescription for MEDROL dose pack, doxycycline (manufacturer unknown) and an unspecified cough syrup. On 19-FEB-2016, the prescription was submitted to the patient. The health care student did not know why the patient received these prescriptions and she stated the following: "she must has been sick" (Malaise) (onset date in 2016). At the time of this report, the outcome of malaise was unknown. The reporter stated that vaccination with ZOSTAVAX and the patient's illness (malaise) was not related. No product quality complaint was involved. Additional information has been requested.
p/vax pt had D for nearly 29 days; p/29th day stool very hard; pt otherwise healthy
Two days after receiving vaccine (5/1) I suddenly lost the ability to taste; Two days after receiving vaccine (5/1) I suddenly lost the ability to smell; The day after receiving vaccine (4/30) I had a severe and debilitating headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 29Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to mollusks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included bupropion (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), terbinafine (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021, the day after receiving vaccine, the patient had a severe and debilitating headache. On 01May2021, two days after receiving vaccine she suddenly lost the ability to taste and smell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. The patient was alarmed because the events appeared to not be a known side effect of the vaccine, so the following day, on 02May2021, she got a Polymerase Chain Reaction (PCR) test done for COVID-19, to see if she had somehow contracted COVID and the result was negative; so, she was sure that the temporary loss of taste and smell was due to the vaccine. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events suddenly lost the ability to taste and smell was resolved on 02May2021, while that of had a severe and debilitating headache was resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Severe headache with neck stiffness, photophobia, low grade fever. Meningitis like symptoms. Any movement of  eyes, neck or back resulted  in ice pick like pain in my head.  Worst headache I have experienced in my life. Severe headache lasted approximately 24 hrs.  I would have assumed this was normal but headache persisted 4+ months.  Prior to vaccine migraines were well controlled with Emgality. After the vaccine, each month x 4 , I developed redness and swelling around my Emgality injection site.
w/in min p/getting vax, infant became very pale & lethargic;would not cry x/w/vigorous sternal rub;pulse-regular & rapid, unable to detect resp;911 called 02 administered per EMT;pt taken to hosp;
arm became very mottled black & blue marks appeared on back of upper arm also back of the hand and raised hive; my arm became very mottled black & blue marks appeared on back of upper arm also back of the hand and raised hive; Tingling around mouth ears scalp and face; Tightness in chest; Itching around lower mouth area; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO151) via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and stroke. Concomitant medications included enalapril (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and clopidogrel (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient had known allergies (unspecified) to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 13:45, the patient arm became very mottled, black and blue marks appeared on back of upper arm also back of the hand and raised hive; had tingling around mouth, ears, scalp and face; tightness in chest and itching around lower mouth area. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events mottled skin, hives, tingling around mouth, ears, scalp and face, tightness in chest and itching around lower mouth area was resolving at the time of report.  No follow-up attempts are needed. No further information is expected.
1st vaccine, arm pain at injection site for 3 days. 2nd vaccine, approx 13 hours after injection, severe body/muscle aches, fatigue, throbbing headache, inability to sleep the night of the vaccine. Used Tylenol after having symptoms for approx 14 hours after onset of symptoms, and it immediately improved all symptoms. Symptoms lasted approx 24 hours, then felt fine. Headache lingered longer, but wasn?t as bad as it was the day after vaccine. Headache gone 52 hours after injection.
Delayed local rxn w/erythema, induration, & edema resolved in 2-3 days;
Acute appendicticis and rupture folloiwng vaccination in a senior with no previous surgeries, comorbidities other than high blood pressure, and no previous vaccine reaction. Appendix ruptures, emergency surgery was agreed upon and this woman is recovering 14 days later at home.
RED RASH ON ARMS THAT HAS SPREAD TO LEGS, BACK, AND BUTTOCKS THAT STARTED DAY OF VACCINATION. PATIENT IS TAKING BENADRYL OTC TO HELP. STILL ONGOING. PATIENT HAS INSTRUCTIONS TO SEEK MEDICAL CARE IF CONDITION WORSENS.
vomitting; cold; Diarrhea; I began experiencing symptoms of flu,; congestion; headache; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0185) via an unspecified route of administration in the left arm on 09May2021 at 16:00(at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, pre-diabetic and insect bite allergy. Concomitant medications included pharmacy. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11May2021, after two days of vaccination, the patient experienced symptoms of flu, congestion and headache. On 14May2021 after five days, experienced  strong headache and went to seek urgent care, they did a COVID-19 test and it was negative. On day seventh day, on 16May2021, the symptoms continued like vomiting, cold, diarrhea and severe headache. The patient went to urgent care again and got a check-up and was provided with an antibiotic. The events resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken which included antibiotics for the reported events. On 14May2021, patient underwent a COVID-19 test and the result was negative. The clinical outcome of the events symptoms of flu, congestion, headache, vomiting, cold, and diarrhea was not recovered, at the time of this report.     No follow-up attempts are possible; No further information is expected.
Patient called pharmacy @ 7:30pm and said he was itching a little and a little redness but I called patient back at 9:00 pm and he said it had gotten better.
Son received vaccine at 2pm. At 10-11pm, he felt a rash on back of his head. He also had a tender lymph node directly below rash.  Rash was blisters on back of skull.  On 8/20/21, his neck tender with movement and has several enlarged lymph nodes right neck. He was taken to doctor and diagnosed with Shingles outbreak and prescribed antiviral medication.
ASSESSMENT AND PLAN:   ESKD - HD MWF - HD today UF 1000 ml achieved - next HD tomorrow AM - I have called dialysis unit and notified them of her covid-19+ status, and they will follow their protocol to accept her tomorrow at regular dialysis time in AM     Anemia - hgb stable - on mircera as outpt, last given dose 6/23/23     Renal MBD - last pth 244 in June - on hectorol 1 mcg IV 3x week     Mechanical fall Rhabdomyolysis - she was on ground for 12 hours - CK 1025 -- > 891 -- > 627 - dc'd IVF     Trop I elevation - borderline elevation - in part elevated due to reduced renal clearance     HTN - continue metoprolol    History of DVT - on apixaban as outpt     COVID-19 - incidental on admission swab - no respiratory symptoms and on room air - on enhanced precautions - de-isolation date 7/13/2023.     Please contact on-call Nephrology with questions   MD         -------------------------------------------- Outpatient Dialysis Handoff Summary (For when patient is discharged)  Code Status: Full Code -------------------------------------------- Changes (if any) are noted below: Dialysis Prescription: No changes as per dialysis orders prior to this admission   Please see discharge summary for complete medication list Patient is covid-19 positive     A discharge summary and last dialysis note should be faxed when available If you do not receive please contact:          Note Details  File Time 7/4/2023  2:58 PM Admit Date 7/3/2023  ED to Hosp-Admission (Discharged) on 7/3/2023  ED to Hosp-Admission (Discharged) on 7/3/2023   Revision History   Detailed Report  Note shared with patient Care Timeline  07/03   Admitted from ED (Observation) 1646 07/04   Discharged 1600
Within a couple hours of the vaccine, in addition to expected arm soreness, I felt tingling up and down arm, then odd feeling throughout my body and head by the afternoon (just very odd, not pain).   I did not have any cold fever or flu-like symptoms.  But, within the next day or two, more concerning symptoms appeared:  I felt, for lack of a better way to describe it, very "twitchy" from my chest, like a flutter.   I've felt restless and fatigued at the same time nearly all the time, like excess energy and exhaustion both at once.  I feel an uncomfortable feeling, like irregular heartbeat or arrhythmia in chest especially at night lying down, which as been interfering with sleep.  I have felt the restlessness and fatigue off and on night and day, interfering with focus and work.  This has gone on for over two months now since the first vaccine dose.  My overall health and how I felt were excellent the day prior to the vaccine.  There is definitely something off with my metabolism, in particular my cardiovascular and aerobic function, since the vaccine that has not yet resolved itself.  I can still exercise and feel better by doing so, but, it always feels at a lower performance level than before the vaccine.  The feeling in my chest, like a harder heartbeat than normal, and sometimes what fits some of the symptoms of congestive heart failure or possibly myocarditis, is most concerning.  I experience some periods where it feels like almost a wheezing in the back of my throat when I breathe.  This was persistent for awhile and now seems to be more off and on, becoming less often.  I am slender, exercise regularly and eat fairly healthy, am fit, and have never had any major health problems.  There definitely seems some kind of cardiovascular, aerobic and/or respiratory effect from the vaccine.
Pt recvd vax & exp hypersensitivity react; pt was seen by MD: No further details were provided
Information has been received on 24-AUG-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 23-SEP-2011, the patient received the ZOSTAVAX (lot number and expiration unknown) unknown route for its intended purpose: the prevention of shingles. As a direct result of the vaccine, the patient suffered from a shingles outbreak, in addition to chronic pain, rash and lesions to various parts of "his" body (in conflict, the patient is female.) The patient did not have a shingles outbreak until 05-JAN-2017. As a direct result of the vaccine, the patient suffered mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of use of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has incurred medical expenses and other economic harm as a direct result of use of ZOSTAVAX. Shingles outbreak was considered to be disabling. Additional information has been requested.
the 2nd Pfizer-BioNTech COVID-19 vaccine was administered on 17Feb2021, she tested positive for COVID-19 on 22Feb2021/chills, fever, fatigue, headache/exposed to COVID between her 1st and 2nd vaccine; the 2nd Pfizer-BioNTech COVID-19 vaccine was administered on 17Feb2021, she tested positive for COVID-19 on 22Feb2021/chills, fever, fatigue, headache/exposed to COVID between her 1st and 2nd vaccine; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. A 31-year-old female patient started received her first and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283 and EN6200), via an unspecified route of administration on 27Jan2021 and on 17Feb2021 both at SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. A patient completed her vaccination schedule, the 2nd Pfizer-BioNTech COVID-19 vaccine was administered on 17Feb2021, she tested positive for COVID-19 on 22Feb2021, asks if a COVID infection may have a negative impact on the vaccine efficacy. Patient had (COVID-like) symptoms for 48 hours after her 2nd vaccination, her husband was exposed to COVID-19 on 14Feb2021 and tested positive on 20Feb2022. She received a positive test result on 22Feb2021, considers she was exposed to COVID between her 1st and 2nd vaccine doses. The patient clarified that her symptoms were fever, chills, headache, and fatigue on the eighteenth through the nineteenth. The patient underwent lab tests and procedures which included covid-19: positive and RTPCRt: positive on 22Feb2021. Outcome of the events was unknown.
Several Painful, swollen, lymph glands under arm, breast,  shoulder areas.  Kept getting worse, after 4 days doctor said take Tylenol or Ibuprofen, which helped.  After a week, swelling is down and no pain.
This case was reported by a pharmacist and described a 50 year old female pt who did not respond to the hep B vaccine recombinant (Engerix B) immunization series. The pt received her first dose of Engerix B on an unspecified date in 2000. She then received her second dose on an unspecified date in June 2003, followed by her third dose on an unspecified date in Oct 2003. Subsequently in Dec 2003 lab work indicated that the pt did not respond.
This spontaneous report as received from a physician refers to a 6 month old patient. On 12-AUG-2014, the patient was vaccinated with the first dose of ROTATEQ (lot # not reported) orally. On 27-OCT-2014, the patient received the second dose of ROTATEQ (lot # not reported) orally and on 04-DEC-2014, the patient received a dose of ROTARIX to complete the 3 dose schedule of rotavirus vaccine. The ROTARIX was given at the patient's age of approximately 24 weeks and 3 days. The physician stated that this was outside of the dosing schedule for ROTARIX. No adverse effect was reported. Additional information has been requested.
Patient complaint of headache, sore throat, chills and fever. No localized inflammation noted at injection site. Instructed by doctor to take Tylenol, gargle with salt water and drink warm tea for sore throat. ER warning signs given. B/P 120/68, Pulse 103, Temp 97.3 F. Positive fetal movement.